A Simple Body Scan May Help Identify Early Signs of Blood Sugar Problems

Researchers found that a painless electrical measurement called phase angle could potentially help detect dysglycemia—a spectrum of blood sugar irregularities ranging from prediabetes to diabetes. This discovery may offer a new screening tool for large populations.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

diagnosisscreeningautoantibodiesstaging

Key takeaways

Phase angle, derived from bioelectrical impedance analysis (BIA), is a measure of body cell health that reflects cell mass, hydration, and membrane integrity
A large study of over 178,000 people found associations between phase angle and different stages of glucose dysregulation, from early prediabetes to established diabetes
The test is non-invasive, quick, and painless—potentially useful for screening many people at once
This is exploratory research showing associations, not proof that phase angle can diagnose or predict diabetes on its own
More research is needed before phase angle could be used as a standalone screening tool in clinical practice

What Is Phase Angle and How Is It Measured?

Phase angle (PhA) is a measurement derived from bioelectrical impedance analysis, or BIA—a simple, non-invasive technique that sends a small electrical current through your body. The measurement reflects how well your body's cells are functioning, including their mass, how much water they contain, and the health of cell membranes.

BIA is already widely used in hospitals and clinics to assess body composition. The phase angle is a raw number that comes directly from the BIA machine, making it easy to calculate without additional testing.

What the Study Found

Researchers analyzed data from a large population-based cohort, including over 178,000 participants aged 19 to 74 years. They measured phase angle and examined how it related to different stages of glucose dysregulation—a spectrum that includes early problems like prediabetes and advanced stages like type 1, type 2, and gestational diabetes.

In people with known type 2 diabetes, researchers also looked at disease duration, current treatment, blood sugar control (measured by hemoglobin A1c), and diabetes-related complications.

In a smaller random sample of 16,153 people without known diabetes, participants underwent oral glucose tolerance tests (OGTT) to detect early glucose problems that hadn't been diagnosed yet. The researchers found associations between phase angle and these early stages of dysglycemia.

What This Might Mean

If phase angle proves reliable, it could offer a quick, painless screening tool for identifying people at risk of dysglycemia across large populations. Because BIA is already available in many clinical settings, phase angle could potentially be added to routine health assessments without much additional cost or complexity.

The measurement appears to capture something meaningful about cellular health that relates to how the body handles blood sugar at different disease stages.

Important Limitations

This was a cross-sectional study, meaning it captured a snapshot of associations at one point in time. It does not prove that phase angle causes dysglycemia or that it can predict who will develop diabetes in the future.

The study identified associations between phase angle and dysglycemia stages, but much more research is needed to understand whether phase angle could be used as a reliable diagnostic or screening tool in everyday clinical practice.

Phase angle should not be used to diagnose, treat, or manage diabetes or prediabetes. Anyone concerned about their blood sugar or diabetes risk should consult with their healthcare provider about appropriate testing and management.

Evidence label

Source: Clinical nutrition (Edinburgh, Scotland). Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.